Xiangying Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiangying Xu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Bin Li
Department of Plastic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
3 shared publicationsBo Sun
2 shared publications- Hulun Li
Department of Neurobiology, Harbin Medical University, Heilongjiang Provincial Key Laboratory of Neurobiology, 157 Bao Jian Road, Harbin 150081, China; Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, China
2 shared publications Jian-Yu Xu
Department of Radiation Oncology, Harbin Medical University, Harbin, Heilongjiang, China :;
2 shared publicationsJianyu Xu
Department of Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
2 shared publicationsLin Chen
2 shared publications
Latest Publications
- Open Access
- 17 June 2020
- Published by Wiley in Global Challenges
- Vol. 4 (8) , 2000008
Relationship between the Young's Modulus and the Crystallinity of Cross‐Linked Poly(ε‐caprolactone) as an Immobilization Membrane for Cancer Radiotherapy
Cancer is a leading cause of death in the world. In cancer radiotherapy, immobilization membranes composed of cross‐linked poly(ε‐caprolactone) (PCL) are utilized for patient positioning. A higher‐dimensional stability of the membrane is urgently required to facilitate more accurate radiation dose delivery. It is extremely important to establish the relationship between the degree of crystallinity and the Young's modulus (E) because it determines the mechanical properties and can be modulated by crystallinity. When two components of the membrane with different strains are in contact, a gradient region adjacent to the interface is formed and confirmed by attenuated total reflection infrared microscopy. Atomic force microscopy (AFM) and Raman spectroscopy are used to scan the same area in the gradient region (14 µm × 14 µm) to characterize E and crystallinity (XRaman), respectively. This co‐localized method ensures the accuracy of the relationship. Finally, 1764 AFM measurement data are processed and 49 pairs of E‐XRaman data are obtained. The regression curve shows that E monotonically increases with XRaman. The nonlinearity of the curve may be attributed to the α‐relaxation and cross‐linking of PCL chains. The chemical structure of this material significantly impacts the mechanical properties, thus requiring future investigation.
- 17 June 2020
- Published by Wiley in Global Challenges
- Vol. 4 (8) , 2000008
Open AccessRelationship between the Young's Modulus and the Crystallinity of Cross‐Linked Poly(ε‐caprolactone) as an Immobilization Membrane for Cancer Radiotherapy
Cancer is a leading cause of death in the world. In cancer radiotherapy, immobilization membranes composed of cross‐linked poly(ε‐caprolactone) (PCL) are utilized for patient positioning. A higher‐dimensional stability of the membrane is urgently required to facilitate more accurate radiation dose delivery. It is extremely important to establish the relationship between the degree of crystallinity and the Young's modulus (E) because it determines the mechanical properties and can be modulated by crystallinity. When two components of the membrane with different strains are in contact, a gradient region adjacent to the interface is formed and confirmed by attenuated total reflection infrared microscopy. Atomic force microscopy (AFM) and Raman spectroscopy are used to scan the same area in the gradient region (14 µm × 14 µm) to characterize E and crystallinity (XRaman), respectively. This co‐localized method ensures the accuracy of the relationship. Finally, 1764 AFM measurement data are processed and 49 pairs of E‐XRaman data are obtained. The regression curve shows that E monotonically increases with XRaman. The nonlinearity of the curve may be attributed to the α‐relaxation and cross‐linking of PCL chains. The chemical structure of this material significantly impacts the mechanical properties, thus requiring future investigation.
- 29 January 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (4) , 4578-4584
Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer
Fatty acid synthase (FASN) is the key enzyme required for the de novo synthesis of long‑chain fatty acids. FASN has been observed to be overexpressed in the majority of cancer tissues, and its expression is associated with a poor prognosis, potentially mediated by resistance to drug or radiation. The present study investigated whether the downregulation of FASN in non‑small cell lung cancer (NSCLC) may increase radiosensitivity. A lentiviral vector containing short hairpin RNA targeted to FASN (pSIH‑H1‑Puro‑shFASN) was successfully constructed and transfected into A549 cells to knockdown the gene by RNA interference. pSIH‑H1‑Puro‑shFASN was used as the experimental group, while pSIH‑H1‑Puro‑shGFP was used as a control group. The mRNA expression levels of FASN were determined using quantitative polymerase chain reaction. In addition, cell proliferation was measured using cell counting kit‑8 assay, and colony formation assay was performed to determine the radiosensitizing effect of FASN knockdown. The cell cycle distribution and apoptotic rates were analyzed using flow cytometry, while western blot analysis was used to assess the expression of DNA‑dependent protein kinase catalytic subunit protein, which is associated with DNA double‑strand break (DSB) repair. The results of the present study revealed that NSCLC cells are more sensitive to radiation following the knockdown of FASN. Furthermore, the increased radiosensitivity may be associated with increased proliferation, promotion of apoptosis and cell cycle arrest in the G2/M phase. Furthermore, downregulated FASN expression reduced the levels of DNA DSB repair‑associated proteins following treatment with radiation. These results indicate that silencing FASN may sensitize NSCLC cells to radiation treatment. Therefore, FASN may be a potential novel therapeutic target to improve the response of NSCLCs to radiation therapy.
- 29 January 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (4) , 4578-4584
Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer
Fatty acid synthase (FASN) is the key enzyme required for the de novo synthesis of long‑chain fatty acids. FASN has been observed to be overexpressed in the majority of cancer tissues, and its expression is associated with a poor prognosis, potentially mediated by resistance to drug or radiation. The present study investigated whether the downregulation of FASN in non‑small cell lung cancer (NSCLC) may increase radiosensitivity. A lentiviral vector containing short hairpin RNA targeted to FASN (pSIH‑H1‑Puro‑shFASN) was successfully constructed and transfected into A549 cells to knockdown the gene by RNA interference. pSIH‑H1‑Puro‑shFASN was used as the experimental group, while pSIH‑H1‑Puro‑shGFP was used as a control group. The mRNA expression levels of FASN were determined using quantitative polymerase chain reaction. In addition, cell proliferation was measured using cell counting kit‑8 assay, and colony formation assay was performed to determine the radiosensitizing effect of FASN knockdown. The cell cycle distribution and apoptotic rates were analyzed using flow cytometry, while western blot analysis was used to assess the expression of DNA‑dependent protein kinase catalytic subunit protein, which is associated with DNA double‑strand break (DSB) repair. The results of the present study revealed that NSCLC cells are more sensitive to radiation following the knockdown of FASN. Furthermore, the increased radiosensitivity may be associated with increased proliferation, promotion of apoptosis and cell cycle arrest in the G2/M phase. Furthermore, downregulated FASN expression reduced the levels of DNA DSB repair‑associated proteins following treatment with radiation. These results indicate that silencing FASN may sensitize NSCLC cells to radiation treatment. Therefore, FASN may be a potential novel therapeutic target to improve the response of NSCLCs to radiation therapy.
- Open Access
- 29 April 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (8) , 3301-3306
Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity
Nucleolin (C23) is an important anti-apoptotic protein that is ubiquitously expressed in exponentially growing eukaryotic cells. In order to understand the impact of C23 in radiation therapy, we attempted to investigate the relationship of C23 expression with the radiosensitivity of human non-small cell lung cancer (NSCLC) cells. We investigated the role of C23 in activating the catalytic subunit of DNA-dependent protein kinase (DNA- PKcs), which is a critical protein for DNA double-strand breaks (DSBs) repair. As a result, we found that the expression of C23 was negatively correlated with the radiosensitivity of NSCLC cell lines. In vitro clonogenic survival assays revealed that C23 knockdown increased the radiosensitivity of a human lung adenocarcinoma cell line, potentially through the promotion of radiation-induced apoptosis and adjusting the cell cycle to a more radiosensitive stage. Immunofluorescence data revealed an increasing quantity of γ-H2AX foci and decreasing radiation-induced DNA damage repair following knockdown of C23. To further clarify the mechanism of C23 in DNA DSBs repair, we detected the expression of DNA-PKcs and C23 proteins in NSCLC cell lines. C23 might participate in DNA DSBs repair for the reason that the expression of DNA-PKcs decreased at 30, 60, 120 and 360 minutes after irradiation in C23 knockdown cells. Especially, the activity of DNA-PKcs phosphorylation sites at the S2056 and T2609 was significantly suppressed. Therefore we concluded that C23 knockdown can inhibit DNA-PKcs phosphorylation activity at the S2056 and T2609 sites, thus reducing the radiation damage repair and increasing the radiosensitivity of NSCLC cells. Taken together, the inhibition of C23 expression was shown to increase the radiosensitivity of NSCLC cells, as implied by the relevance to the notably decreased DNA-PKcs phosphorylation activity at the S2056 and T2609 clusters. Further research on targeted C23 treatment may promote effectiveness of radiotherapy and provide new targets for NSCLC patients.
- 29 April 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (8) , 3301-3306
Open AccessKnocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity
Nucleolin (C23) is an important anti-apoptotic protein that is ubiquitously expressed in exponentially growing eukaryotic cells. In order to understand the impact of C23 in radiation therapy, we attempted to investigate the relationship of C23 expression with the radiosensitivity of human non-small cell lung cancer (NSCLC) cells. We investigated the role of C23 in activating the catalytic subunit of DNA-dependent protein kinase (DNA- PKcs), which is a critical protein for DNA double-strand breaks (DSBs) repair. As a result, we found that the expression of C23 was negatively correlated with the radiosensitivity of NSCLC cell lines. In vitro clonogenic survival assays revealed that C23 knockdown increased the radiosensitivity of a human lung adenocarcinoma cell line, potentially through the promotion of radiation-induced apoptosis and adjusting the cell cycle to a more radiosensitive stage. Immunofluorescence data revealed an increasing quantity of γ-H2AX foci and decreasing radiation-induced DNA damage repair following knockdown of C23. To further clarify the mechanism of C23 in DNA DSBs repair, we detected the expression of DNA-PKcs and C23 proteins in NSCLC cell lines. C23 might participate in DNA DSBs repair for the reason that the expression of DNA-PKcs decreased at 30, 60, 120 and 360 minutes after irradiation in C23 knockdown cells. Especially, the activity of DNA-PKcs phosphorylation sites at the S2056 and T2609 was significantly suppressed. Therefore we concluded that C23 knockdown can inhibit DNA-PKcs phosphorylation activity at the S2056 and T2609 sites, thus reducing the radiation damage repair and increasing the radiosensitivity of NSCLC cells. Taken together, the inhibition of C23 expression was shown to increase the radiosensitivity of NSCLC cells, as implied by the relevance to the notably decreased DNA-PKcs phosphorylation activity at the S2056 and T2609 clusters. Further research on targeted C23 treatment may promote effectiveness of radiotherapy and provide new targets for NSCLC patients.
- 23 April 2015
- Published by Wiley in Histopathology
- Vol. 67 (6) , 817-826
The expression of astrocyte elevated gene‐1 in human non‐small‐cell lung cancer and its relationship with postoperative chemotherapy and radiotherapy
Aims: To examine the expression of astrocyte elevated gene‐1 (AEG‐1) in non‐small‐cell lung cancer (NSCLC) and analyse the correlation between AEG‐1 expression and the prognosis of the patients, particularly the relationship between AEG‐1 expression and postoperative chemotherapy and radiotherapy.Methods: The expression of AEG‐1 was analysed by immunohistochemistry in 225 primary NSCLC specimens and 42 adjacent normal lung tissue specimens. Statistical analyses were performed to evaluate the correlation between AEG‐1 expression and the clinicopathological characteristics of the patients as well as the predictive value of AEG‐1.Results: The expression of AEG‐1 was associated with the pathological stage (P < 0.001) and lymph node status (P = 0.028). A multivariate analysis indicated that AEG‐1 expression was an independent prognostic factor for both overall survival (OS) and disease‐free survival (DFS). In the postoperative chemotherapy group, the OS (P = 0.014) and DFS (P = 0.009) in the low AEG‐1 expression group were longer than the survival times in the high AEG‐1 expression group. In the postoperative radiotherapy group, the local recurrence‐free survival was significantly shorter in patients whose tumours showed high AEG‐1 expression (P = 0.016).Conclusions: AEG‐1 expression could be a predictor for OS and DFS in NSCLC patients. Patients with low AEG‐1 expression received the greatest benefit from both postoperative chemotherapy and radiotherapy.
- 23 April 2015
- Published by Wiley in Histopathology
- Vol. 67 (6) , 817-826
The expression of astrocyte elevated gene‐1 in human non‐small‐cell lung cancer and its relationship with postoperative chemotherapy and radiotherapy
Aims: To examine the expression of astrocyte elevated gene‐1 (AEG‐1) in non‐small‐cell lung cancer (NSCLC) and analyse the correlation between AEG‐1 expression and the prognosis of the patients, particularly the relationship between AEG‐1 expression and postoperative chemotherapy and radiotherapy.Methods: The expression of AEG‐1 was analysed by immunohistochemistry in 225 primary NSCLC specimens and 42 adjacent normal lung tissue specimens. Statistical analyses were performed to evaluate the correlation between AEG‐1 expression and the clinicopathological characteristics of the patients as well as the predictive value of AEG‐1.Results: The expression of AEG‐1 was associated with the pathological stage (P < 0.001) and lymph node status (P = 0.028). A multivariate analysis indicated that AEG‐1 expression was an independent prognostic factor for both overall survival (OS) and disease‐free survival (DFS). In the postoperative chemotherapy group, the OS (P = 0.014) and DFS (P = 0.009) in the low AEG‐1 expression group were longer than the survival times in the high AEG‐1 expression group. In the postoperative radiotherapy group, the local recurrence‐free survival was significantly shorter in patients whose tumours showed high AEG‐1 expression (P = 0.016).Conclusions: AEG‐1 expression could be a predictor for OS and DFS in NSCLC patients. Patients with low AEG‐1 expression received the greatest benefit from both postoperative chemotherapy and radiotherapy.
- Open Access
- 16 August 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e70727
Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair
Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects of enhancing cancer cell radiosensitivity. Lung cancer A549 cells and breast cancer MCF-7 cells were pretreated with or without nimotuzumab for 24 h before radiation to perform the clonogenic survival assay and to analyze the cell apoptosis by flow ctyometry. γ-H2AX foci were detected by confocal microscopy to assess the effect of nimotuzumab on radiation induced DNA repair. EGFR activation was examined and the levels of DNA damage repair related proteins in A549 cells at different time point and at varying doses exposure after nimotuzumab and radiation treatment were examined by Western blot. Pretreatment with nimotuzumab reduced clonogenic survival after radiation, inhibited radiation-induced EGFR activation and increased the radiation-induced apoptosis in both A549 cells and MCF-7 cells. The foci of γ-H2AX 24 h after radiation significantly increased in nimotuzumab pretreated cells with different doses. The phosphorylation of AKT and DNA-PKcs were remarkably inhibited in the combination group at each dose point as well as time point. Our results revealed that the possible mechanism of nimotuzumab enhancing the cancer radiosensitivity is that nimotuzumab inhibited the radiation-induced activation of DNA-PKcs through blocking the PI3K/AKT pathway, which ultimately affected the DNA DSBs repair.
- 16 August 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e70727
Open AccessNimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair
Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects of enhancing cancer cell radiosensitivity. Lung cancer A549 cells and breast cancer MCF-7 cells were pretreated with or without nimotuzumab for 24 h before radiation to perform the clonogenic survival assay and to analyze the cell apoptosis by flow ctyometry. γ-H2AX foci were detected by confocal microscopy to assess the effect of nimotuzumab on radiation induced DNA repair. EGFR activation was examined and the levels of DNA damage repair related proteins in A549 cells at different time point and at varying doses exposure after nimotuzumab and radiation treatment were examined by Western blot. Pretreatment with nimotuzumab reduced clonogenic survival after radiation, inhibited radiation-induced EGFR activation and increased the radiation-induced apoptosis in both A549 cells and MCF-7 cells. The foci of γ-H2AX 24 h after radiation significantly increased in nimotuzumab pretreated cells with different doses. The phosphorylation of AKT and DNA-PKcs were remarkably inhibited in the combination group at each dose point as well as time point. Our results revealed that the possible mechanism of nimotuzumab enhancing the cancer radiosensitivity is that nimotuzumab inhibited the radiation-induced activation of DNA-PKcs through blocking the PI3K/AKT pathway, which ultimately affected the DNA DSBs repair.
- 27 October 2011
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 12 (7) , 610-616
Effects of IL-17A on the occurrence of lung adenocarcinoma
The relationship between IL-17A and cancer, whether beneficial or antagonistic, continues to be a controversial issue. In this study, effects of IL-17A on lung adenocarcinoma were investigated using lung cancer cell lines, 95D and 95C. In the presence or absence of IL-17A, cell proliferation and VEGF secretion were detected. Effects of IL-17A on capillary networks and process of angiogenesis were also evaluated. In vivo, the level of IL-17A was assayed in the serum of lung adenocarcinoma patients. At the same time, slices of adenocarcinoma tissue were analyzed for expression of IL-17A, its receptor (IL-17RA), VEGF, CD4+-IL-17A+ cells and CD8+-IL-17A+ cells by immunohistochemistry and immunofluorescence assays. IL-17A did not have effect on the proliferation of 95D or 95C cells, however, the elevated expression of VEGF in supernatant of 95D or 95C cells was found to be IL-17A concentration-dependent. Supernatants from 95D or 95C cells treated with IL-17A could obviously facilitate angiogenesis, compared with IL-17A absence group (P < 0.01). Higher levels of IL-17A were detected in serum of patients with lung adenocarcinoma than healthy controls (P < 0.001). Higher positive expressions of IL-17A, IL-17RA and VEGF were confirmed in lung adenocarcinoma lesion tissues compared to pericancerous normal tissues (P < 0.001). Tnc17 cells, as well as Th17 cells were found in adenocarcinoma tissue, indicating a potential role of these cells in disease. In summary, IL-17A might affect lung adenocarcinoma by promoting angiogenesis, while the role of Tnc17 cells or Th17 cells remains to be elucidated.
- 27 October 2011
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 12 (7) , 610-616
Effects of IL-17A on the occurrence of lung adenocarcinoma
The relationship between IL-17A and cancer, whether beneficial or antagonistic, continues to be a controversial issue. In this study, effects of IL-17A on lung adenocarcinoma were investigated using lung cancer cell lines, 95D and 95C. In the presence or absence of IL-17A, cell proliferation and VEGF secretion were detected. Effects of IL-17A on capillary networks and process of angiogenesis were also evaluated. In vivo, the level of IL-17A was assayed in the serum of lung adenocarcinoma patients. At the same time, slices of adenocarcinoma tissue were analyzed for expression of IL-17A, its receptor (IL-17RA), VEGF, CD4+-IL-17A+ cells and CD8+-IL-17A+ cells by immunohistochemistry and immunofluorescence assays. IL-17A did not have effect on the proliferation of 95D or 95C cells, however, the elevated expression of VEGF in supernatant of 95D or 95C cells was found to be IL-17A concentration-dependent. Supernatants from 95D or 95C cells treated with IL-17A could obviously facilitate angiogenesis, compared with IL-17A absence group (P < 0.01). Higher levels of IL-17A were detected in serum of patients with lung adenocarcinoma than healthy controls (P < 0.001). Higher positive expressions of IL-17A, IL-17RA and VEGF were confirmed in lung adenocarcinoma lesion tissues compared to pericancerous normal tissues (P < 0.001). Tnc17 cells, as well as Th17 cells were found in adenocarcinoma tissue, indicating a potential role of these cells in disease. In summary, IL-17A might affect lung adenocarcinoma by promoting angiogenesis, while the role of Tnc17 cells or Th17 cells remains to be elucidated.
- 1 January 2011
- Published by Taylor & Francis in Immunological Investigations
- Vol. 40 (5) , 535-551
Modeled Microgravity Suppressed Expansion of the MBP-specific T Lymphocytes of Rats with Experimental Autoimmune Encephalomyelitis
Experimental autoimmune encephalomyelitis (EAE) is characterized by uncontrolled proliferation of autoreactive T lymphocytes, with markedly increased secretion of pro-inflammatory cytokines. To further dissect the pathogenetic pathways of this disease, we exposed T lymphocytes from EAE rats, which were specific for myelin basic protein (MBP) to a modeled microgravity (MMG) environment, using a rotated cell culture system (RCCS) that was known to suppress proliferation of normal T cells. Following exposure to MMG, the proliferation of EAE lymphocytes decreased dramatically compared to those cultured in unit gravity (UG). At the beginning of MMG, a significant increase of apoptosis of MBP-specific T lymphocytes was observed, while at a later stage, the cytokine secretion profile of exposed MBP-specific T lymphocytes was altered, as was the differentiation of Th subsets. We concluded that the function of MBP-specific T lymphocytes was disordered after exposure to MMG.
- 1 January 2011
- Published by Taylor & Francis in Immunological Investigations
- Vol. 40 (5) , 535-551
Modeled Microgravity Suppressed Expansion of the MBP-specific T Lymphocytes of Rats with Experimental Autoimmune Encephalomyelitis
Experimental autoimmune encephalomyelitis (EAE) is characterized by uncontrolled proliferation of autoreactive T lymphocytes, with markedly increased secretion of pro-inflammatory cytokines. To further dissect the pathogenetic pathways of this disease, we exposed T lymphocytes from EAE rats, which were specific for myelin basic protein (MBP) to a modeled microgravity (MMG) environment, using a rotated cell culture system (RCCS) that was known to suppress proliferation of normal T cells. Following exposure to MMG, the proliferation of EAE lymphocytes decreased dramatically compared to those cultured in unit gravity (UG). At the beginning of MMG, a significant increase of apoptosis of MBP-specific T lymphocytes was observed, while at a later stage, the cytokine secretion profile of exposed MBP-specific T lymphocytes was altered, as was the differentiation of Th subsets. We concluded that the function of MBP-specific T lymphocytes was disordered after exposure to MMG.